ImmuneOncia is a South Korea-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Business Model:
Revenue: $1.5M
Employees: 11-50
Address: 15, Pangyo-ro 228beon-gil
City: Seongnam-si
State: gyeonggido
Zip: 13487
Country: KR
ImmuneOncia is a South Korea-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Pre-IPO | $20.5M |
Yuhan Corporation Premier Partners, LLC K2 Investment Partners LLC Mertis Capital Partners Group AG BNH Investment E & Investment Hanyang Securities |
2/2019 | Equity | 1 | $40M |
Paratus Investment Paratus Investment |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|